Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | HCID 22747447 | HCID 22747447 | — |
| Reactant | 4-[(1-Methyl-1H-pyrazol-3-yl)amino]quinazolin-6-ol | HCID 23160382 | — |
| Reactant | HCID 178418922 | HCID 178418922 | — |
| Solvent | Dimethylacetamide | HCID 31374 | — |
| Product | HCID 23160358 | HCID 23160358 | 28.1% |
Reaction Steps
4-[(1-Methyl-1H-pyrazol-3-yl)amino]quinazolin-6-ol (250 mg; 1.033 mmol) and 424 mg (2.219 mmol) of the above-prepared sulfone compound were added to a solution of 320 mg (2.857 mmol) of tert-butoxy potassium in 24 ml of N,N-dimethylacetamide and the mixture was stirred at 77° C. for 12 hours. To the reaction solution was added water followed by extracting with chloroform. The organic layer was dried and concentrated and the resulting residue was purified by a reversed phase preparative HPLC (0.1% TFA-containing water:acetonitrile=90:10→10:90) to give 120 mg (yield: 28%) of the title compound as a yellow solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07687502B2 |
|---|
| Source dataset | uspto-grants-2010_03 |
|---|
| ORD ID | ord-ce014e2564ba4187bd00af1d48be365b |
|---|
| Source note | uspto-grants-2010_03 |
|---|